Hosted on MSN14h
FDA cancels meeting to pick flu vaccine strains for winter without explanation
The Food and Drug Administration on Wednesday canceled a planned March 13 committee meeting to update next winter's flu shot.
Food Dive13h
FDA delays crackdown on which foods can be labeled ‘healthy’
The rule would prevent many cereal and yogurt products from making nutrition claims and allow nuts, oils and certain seafood ...
FDA cancels March meeting on flu vaccine composition without explanation
The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...
FDA meeting to choose flu vaccine composition canceled without explanation
A March meeting of outside advisers to the United States Food and Drug Administration to discuss the composition of flu ...
Trying to eat healthy? FDA has a couple of changes to make it easier. What to know
"Under the updated 'healthy' claim, nutrient-dense foods that are encouraged by the Dietary Guidelines — vegetables, fruits, ...
JD Supra3d
FDA Reveals AI Development Cheat Sheet in Highly Anticipated Draft Guidances
Early in the new year, the US Food and Drug Administration (FDA) released two anticipated draft guidance documents focused on artificial ...
JD Supra3d
Preparing for 2025: Key Trends in FDA Guidance Agendas
In January 2025, various US Food and Drug Administration (FDA) centers and offices published their guidance agendas for the 2025 calendar year ...
Fierce Healthcare6d
FDA declares semaglutide shortage over, spelling end to compounded GLP-1 market, for now
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
Viatris Falls to 52-Week Low; FDA Import Alert for India Facility Weighs on Guidance
Viatris shares fell to a 52-week low after the drug company said issues related to a India facility are expected to hurt 2025 total revenue by about $500 million. The stock was recently down 14% to $9 ...
Becker's Hospital Review3d
FDA sets deadline to end sales of Ozempic, Wegovy copycats
Semaglutide — the key ingredient in Ozempic and Wegovy — had been in shortage since 2022. Now that supply has stabilized, state-licensed compounding pharmacies and physicians must stop selling ...